Top Markets
#1 Purr Purr +54.31%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 ApeX ApeX +22.22%
#4 Pons Pons +21.14%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +19.69%
#6 Zora Zora +18.56%
#7 Non-Playable Coin Non-Playable Coin +18.52%
#8 龙虾 (Lobster) 龙虾 (Lobster) +17.64%
#9 OriginTrail OriginTrail +17.52%
#10 Pendle Pendle +16.17%
Coin of the day
Purr Purr
設定
言語
日本
通貨
USD
テーマ
Beijing Biostar Pharms Co Ltd Beijing Biostar Pharms Co Ltd

Beijing Biostar Pharms Co Ltd

2563
株式のランク #21402
Beijing Biostar Pharmaceuticals Co. Ltd. primarily focuses on developing... Beijing Biostar Pharmaceuticals Co. Ltd. primarily focuses on developing innovative therapies for tumors. The company is dedicated to creating novel anti-cancer drugs, each secured by independent intellectual property rights. A prominent product in its portfolio is the Utidelone injection, a next-generation microtubule inhibitor produced through a unique microbial fermentation process. This enterprise was co-founded by Li Tang and Rong Guo Qiu on July 11, 2002, and operates from its headquarters in Beijing, China.
株価
$0.44774181
最終同期: 2026-08-21
時価総額
$108.23M
変化（1日）
2.19%
変化（1年）
-61.12%
国
CN
取引 Beijing Biostar Pharms Co Ltd (2563)

カテゴリー

Healthcare
Beijing Biostar Pharms Co Ltd（2563）のP/B比率
2026 時点のP/B比率 TTM: 0
Beijing Biostar Pharms Co Ltd の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
Beijing Biostar Pharms Co Ltd の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH